info@birdgroup.be

Login

Papers

Nature Genetics, January 2011, Volume 43, Number 1
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

Nature Genetics, November 2011, Volume 43, Number 11
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease

Am. J. Hum. Genet. 68:1165-1171, 2001
International Collaboration Provides Convincing Linkage Replication in Complex Disease through Analysis of a Large Pooled Data Set: Crohn Disease and Chromosome 16

Humn Molecular Genetics, 2004, Volume 13, Number 7
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs

Inflamm Bowel Dis. 2018 Apr 23;24(5):1099-1105
Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Inflamm Bowel Dis. 2018 Jun 15. doi: 10.1093/ibd/izy219. [Epub ahead of print]
Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.

Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):49-53.
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

United European Gastroenterology Journal, First Published 20 Jun 2018.
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice

‹
1
2
3
4
5
6
›